MedPath

"TransRadial Ultra Support Technique" (TRUST)

Not Applicable
Completed
Conditions
Coronary Arterioscleroses
Coronary Artery Disease
Interventions
Procedure: Anchoring Technique
Procedure: TRUST technique
Procedure: Coronary stenting
Registration Number
NCT03025685
Lead Sponsor
Meshalkin Research Institute of Pathology of Circulation
Brief Summary

Adequate support is required for challenging percutaneous coronary interventions (PCI). The "TransRadial Ultra Support Technique" (TRUST technique) is a new support technique that provides active support by deep pass of the coronary wire into the heart cavities (left ventricle-LV, right ventricle-RV) or aorta.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
54
Inclusion Criteria
  • Subjects singed informed consent form
  • Subjects eligible for percutaneous coronary intervention
Exclusion Criteria
  • Age <18 years or >75 years
  • Subject has a platelet count < 100,000 cells/mm3 or > 700,000 cells/mm3.
  • Known non-adherence to double anti-platelet therapy (DAPT)
  • LVEF <30%
  • Continuing bleeding
  • Acute coronary syndrome (ST-elevation Myocardial infarction)
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Anchoring technique + Coronary StentingAnchoring TechniquePCI with coronary stenting using Wire Anchoring Pass technique for support improvement
TRUST technique + Coronary StentingTRUST techniquePCI with coronary stenting using TransRadial Ultra Support technique for support improvement
Anchoring technique + Coronary StentingCoronary stentingPCI with coronary stenting using Wire Anchoring Pass technique for support improvement
TRUST technique + Coronary StentingCoronary stentingPCI with coronary stenting using TransRadial Ultra Support technique for support improvement
Primary Outcome Measures
NameTimeMethod
Procedural success1 week after PCI

Device success without the occurrence of in-hospital MACCE

Device successIntraoperative

Achievement of a final residual diameter stenosis \<20% and a TIMI 3 flow in the target vessel

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

State Research Institute of CIrculation Pathology

🇷🇺

Novosibirsk, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath